taiba pharma group Sets Up New Manufacturing Company “MENAGENE”
taiba Healthcare Group announces setting up “MENAGENE PHARMACEUTICAL INDUSTRIES ” for developing and manufacturing innovative specialty products in the Middle East/North Africa region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180604005774/en/
MENAGENE is located in Muscat, Oman (part of GCC countries) and is expected to be operational in the beginning of 2020. It will acquire market authorization rights for the MENA region and provide high quality products and services to all customers and stakeholders in the Middle East. taiba strategic plan consists of an investment on MENAGENE of approx. $50 million and this new strategy strengthens taiba group position in addressing the needs of the Middle East market.
The CEO of taiba group , Dr Saif Al Hasani is strongly committed to bringing access for patients to innovative treatments and cover the high unmet patient needs in the MENA region. He highlights that the key success factors of the company are its cooperation with reputable international partners, its investment on high caliber people, the deep understanding of the specialty and rare disease products and the culture of the stakeholders in the Middle East. taiba commits to invest the needed resources to maximize impact and benefit to patients in the region.
taiba group is a leading healthcare company focusing on niche therapeutic segments including rare diseases and orphan products in the MENA region. taiba has regional HQ in Dubai and logistics hubs in GCC countries and reaches all of the MENA region. taiba is privately held with 130 employees and has had a robust annual growth for over 5 consecutive years with annual sales of $150 million in 2017. taiba’s leading international partners include Alexion, Biomarin, Vertex, Aegerion, Veloxis, etc. and is well known in the therapeutic areas of Hematology/Oncology, Genetics/Metabolics, Transplantation and other Specialty orphan diseases. taiba is able to adapt its business model according to the needs of the partners and in fulfilling the needs of the market.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
AZ-UNIVERSAL-LASER19.6.2018 14:07 | pressemeddelelse
Universal Laser Systems Expands Its Materials Database with Henkel, Hexcel and Saint-Gobain Materials
NY-VALENCE-GROUP19.6.2018 13:59 | pressemeddelelse
Valence Advises Itaúsa on Sale of Brazilian Chemical Co Elekeiroz to H.I.G. Capital
CA-DOLE-FOOD-COMPANY19.6.2018 12:02 | pressemeddelelse
Dole Adds Industry Veteran Michael Solomon as President of Dole Fresh Vegetables
ENAMINE19.6.2018 10:10 | pressemeddelelse
Enamine and TBD Biodiscovery Collaborate to Provide GMP-Based Services
IDEMIA19.6.2018 09:56 | pressemeddelelse
IDEMIA Selected to Deliver Its Next Generation Fingerprint Matcher Engine as Part of the UK Home Office Biometrics Programme
NJ-BINARY-TREE19.6.2018 09:02 | pressemeddelelse
Vincent Fournier Joins Binary Tree as Chief Innovation Officer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum